Paul Nitschmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Paul Nitschmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Paul Nitschmann Today - Breaking & Trending Today

Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC

Published: February 29, 2024

SNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401 as...

Source: marketscreener.com

Related Topics:

Paul NitschmannAdvisory CommitteeRegulatory Affairs At InterceptDrug AdministrationGlobenewswire IncInternational Normalized RatioIntercept Pharmaceuticals IncNew Drug ApplicationPrescription Drug User Fee ActSenior Vice PresidentRegulatory AffairsNarrow TherapeuticBile Salt EffluxFull Prescribing InformationIntercept Pharmaceuticals

Intercept Pharmaceuticals, inc (ICPT) Q3 2021 Earnings Call Transcript

Published: November 3, 2021

ICPT earnings call for the period ending September 30, 2021.

Source: fool.com

Related Topics:

United StatesGail CawkwellPaul NitschmannJerome DursoEliana MerleLinda RichardsonSalveen Richter Goldman SachsMayank MamtaniAlethia YoungM Michelle BerreyJerry DursoMichael YeeMatthew LuchiniBrian AbrahamsEmily Bodnar Cantor FitzgeraldSalveen RichterGeoff MeachamSwapnil Piper SandlerPiper SandlerMichael Yee JefferiesMichelle BerreyYasmeen RahimiThomas SmithMayank Mamtanib RileyAnvita Gupta Cowen